SMTI
Price
$33.74
Change
-$0.20 (-0.59%)
Updated
Aug 28, 04:57 PM (EDT)
Capitalization
300.28M
81 days until earnings call
STXS
Price
$2.81
Change
-$0.05 (-1.74%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
254.74M
70 days until earnings call
Interact to see
Advertisement

SMTI vs STXS

Header iconSMTI vs STXS Comparison
Open Charts SMTI vs STXSBanner chart's image
Sanara MedTech
Price$33.74
Change-$0.20 (-0.59%)
Volume$100
Capitalization300.28M
Stereotaxis
Price$2.81
Change-$0.05 (-1.74%)
Volume$1.71K
Capitalization254.74M
SMTI vs STXS Comparison Chart in %
Loading...
SMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SMTI vs. STXS commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMTI is a Buy and STXS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (SMTI: $33.94 vs. STXS: $2.87)
Brand notoriety: SMTI and STXS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SMTI: 27% vs. STXS: 55%
Market capitalization -- SMTI: $300.28M vs. STXS: $254.74M
SMTI [@Pharmaceuticals: Other] is valued at $300.28M. STXS’s [@Pharmaceuticals: Other] market capitalization is $254.74M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SMTI’s FA Score shows that 0 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • SMTI’s FA Score: 0 green, 5 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, STXS is a better buy in the long-term than SMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SMTI’s TA Score shows that 5 TA indicator(s) are bullish while STXS’s TA Score has 5 bullish TA indicator(s).

  • SMTI’s TA Score: 5 bullish, 5 bearish.
  • STXS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, STXS is a better buy in the short-term than SMTI.

Price Growth

SMTI (@Pharmaceuticals: Other) experienced а +10.45% price change this week, while STXS (@Pharmaceuticals: Other) price change was +0.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.19%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was +21.40%.

Reported Earning Dates

SMTI is expected to report earnings on Nov 17, 2025.

STXS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+4.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMTI($300M) has a higher market cap than STXS($255M). STXS YTD gains are higher at: 25.877 vs. SMTI (2.229). SMTI has higher annual earnings (EBITDA): 147K vs. STXS (-22.41M). SMTI has more cash in the bank: 17M vs. STXS (6.97M). STXS has less debt than SMTI: STXS (5.73M) vs SMTI (45.5M). SMTI has higher revenues than STXS: SMTI (97.2M) vs STXS (31.8M).
SMTISTXSSMTI / STXS
Capitalization300M255M118%
EBITDA147K-22.41M-1%
Gain YTD2.22925.8779%
P/E RatioN/AN/A-
Revenue97.2M31.8M306%
Total Cash17M6.97M244%
Total Debt45.5M5.73M794%
FUNDAMENTALS RATINGS
SMTI vs STXS: Fundamental Ratings
SMTI
STXS
OUTLOOK RATING
1..100
2078
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
72100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
4340
P/E GROWTH RATING
1..100
10058
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SMTI's Valuation (81) in the null industry is in the same range as STXS (100) in the Medical Specialties industry. This means that SMTI’s stock grew similarly to STXS’s over the last 12 months.

SMTI's Profit vs Risk Rating (72) in the null industry is in the same range as STXS (100) in the Medical Specialties industry. This means that SMTI’s stock grew similarly to STXS’s over the last 12 months.

SMTI's SMR Rating (96) in the null industry is in the same range as STXS (100) in the Medical Specialties industry. This means that SMTI’s stock grew similarly to STXS’s over the last 12 months.

STXS's Price Growth Rating (40) in the Medical Specialties industry is in the same range as SMTI (43) in the null industry. This means that STXS’s stock grew similarly to SMTI’s over the last 12 months.

STXS's P/E Growth Rating (58) in the Medical Specialties industry is somewhat better than the same rating for SMTI (100) in the null industry. This means that STXS’s stock grew somewhat faster than SMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SMTISTXS
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
80%
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
SMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SITS0.04N/A
+13.03%
Southern ITS International Inc.
DASTY31.160.36
+1.17%
Dassault Systemes SA
NXDCF9.38N/A
N/A
NEXTDC Ltd, Brisbane QLD
TBIIF0.35N/A
N/A
Tobii Technology AB
DPUKY5.59-0.24
-4.12%
Dominos Pizza UK and IRL Plc.

SMTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMTI has been loosely correlated with A. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SMTI jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMTI
1D Price
Change %
SMTI100%
+0.86%
A - SMTI
47%
Loosely correlated
+0.33%
NTRA - SMTI
45%
Loosely correlated
-1.61%
MTD - SMTI
44%
Loosely correlated
+0.04%
TWST - SMTI
44%
Loosely correlated
-1.91%
IQV - SMTI
44%
Loosely correlated
+0.55%
More

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with TWST. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
+3.24%
TWST - STXS
36%
Loosely correlated
-1.91%
CERS - STXS
35%
Loosely correlated
-1.50%
SMTI - STXS
35%
Loosely correlated
+0.86%
RGEN - STXS
33%
Loosely correlated
-1.34%
VCYT - STXS
33%
Poorly correlated
-1.58%
More